SCHEMBL29348405

SCHEMBL29348405

CC(c1ccc(-c2cccc(C3CCC(O)NC3=O)c2Cl)cc1)n1ccccc1=O

nearest known ligand 0.31

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
MET P08581 1/20 0.31
BRD4 O60885 1/20 0.31
CREBBP Q92793 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31068270 0.84 DDB1 (0.43) BRD4CREBBP
SCHEMBL29348204 0.82 F10 (0.37)
SCHEMBL29348407 0.73 PDCD1 (0.33)
SCHEMBL29348462 0.73 ELANE (0.33)
SCHEMBL29348429 0.71 CNR2 (0.32) BRD4CREBBP
SCHEMBL29348423 0.71 NR1I2 (0.35)
SCHEMBL29348514 0.70 TSHR (0.35)
SCHEMBL29348458 0.69 CNR2 (0.31)
SCHEMBL29348508 0.69 GRM2 (0.33)
SCHEMBL29348202 0.66 DDB1 (0.45)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024151547-A1 TARGETED DEGRADATION OF VAV1 MONTE ROSA THERAPEUTICS, INC. (US) 2024-07-18 WO disclosed